Information  X 
Enter a valid email address

Medica Group PLC (MGP)

  Print   

Friday 28 May, 2021

Medica Group PLC

Director/PDMR Shareholding

RNS Number : 2465A
Medica Group PLC
28 May 2021
 

Medica Group PLC

 

Director / PDMR Shareholding

 

Medica Group PLC (the "Company") announces that on 26 May 2021, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Deferred Bonus Plan 2017 at a nil exercise price:

 

Name of PDMR

Number of shares subject to option

Stuart Quin


17,035

Richard Jones


 5,010

Stephen Davies


10,020

 

 

The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation, and set out more details of the transactions.

 

1.

Details of PDMR

(a)

Name

1.  Stuart Quin

2.  Richard Jones

3.  Stephen Davies

 

2.

Reason for notification

(b)

Position / status

1.  Chief Executive Officer

2.  Chief Financial Officer

3.  Medical Director

 

Initial notification / amendment

Initial notification in each case

3.

Details of the Issuer

(a)

Name

Medica Group PLC

(b)

LEI

213800B8XE5FUSZF5Z16

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")

(b)

Nature of the transaction

Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017

(c)

Price(s) and volume

Option Price nil in each case

1. 17,035

2. 5,010

3.  10,020 

(d)

Aggregated information

N/A

(e)

Date of the transaction

26 May 2021

(f)

Place of the transaction

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKFBNNBKDBPB

a d v e r t i s e m e n t